Douglas Flora: Worthy read from Frank Austin Nothaft and Brad Power in AI in Precision Oncology

Douglas Flora shared a post on LinkedIn:

“Proud to Publish!

I’m excited to share a truly interesting take from Frank Austin Nothaft and Brad Power in AI in Precision Oncology. They leverage Clayton Christensen’s “jobs to be done” framework to bring AI directly to patients, empowering them to actively participate in all aspects of their care. Their brilliant concepts could solve many of the problems healthcare faces today.

As they highlight, “AI-enabled services have the potential to allow all patients and caregivers to access personalized care and navigation services, regardless of health literacy or resource barriers.”

Congratulations, Frank and Brad, on this insightful and impactful work!

Worthy read—don’t miss it: Read the full article here.”

The Most Disruptive Near-Term Use of AI in Cancer Care: Patient Empowerment Through Software Agents

Authors:  Frank Nothaft and Brad Power

Source: Douglas Flora/LinkedIn

Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health.

As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.